BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 320231)

  • 1. Colony-forming ability of marrow from patients receiving immunotherapy during chemotherapy-induced remission in acute myeloid leukaemia.
    Gordon MY; Powles RL; Douglas ID
    J Clin Pathol; 1977 Jan; 30(1):70-5. PubMed ID: 320231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute leukemia in adults: assessment of remission induction with combination chemotherapy by clinical and cell-culture criteria.
    Curtis JE; Cowan DH; Bergsagel DE; Hasselback R; McCulloch EA
    Can Med Assoc J; 1975 Aug; 113(4):289-94. PubMed ID: 1056807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.G.
    Gutterman JU; Hersh EM; Rodriguez V; McCredie KB; Mavligit G; Reed R; Burgess MA; Smith T; Gehan E; Bodey GP; Freireich EJ
    Lancet; 1974 Dec; 2(7894):1405-9. PubMed ID: 4140327
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter: Bone-marrow culture in acute myeloid leukaemia.
    Goldman JM; Buskard NA; Th'ng KH
    Lancet; 1976 Jul; 2(7979):260. PubMed ID: 59277
    [No Abstract]   [Full Text] [Related]  

  • 5. Active specific immunotherapy for acute myelogenous leukaemia.
    Powles R
    Johns Hopkins Med J Suppl; 1974; 3():333-40. PubMed ID: 4609353
    [No Abstract]   [Full Text] [Related]  

  • 6. Remission of acute myeloid leukemia: studies of in vitro colony formation by bone marrow cells.
    Galbraith PR
    Can Med Assoc J; 1974 May; 110(10):1147-50. PubMed ID: 4524532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nature of remission in acute myeloblastic leukaemia.
    Powles RL; Selby PJ; Palu G; Morgenstern G; McElwain TJ; Clink HM; Alexander P
    Lancet; 1979 Sep; 2(8144):674-6. PubMed ID: 90762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active immunotherapy in acute myelogenous leukaemia and the induction of second and subsequent remissions.
    Harris R; Zuhrie SR; Freeman CB; Taylor GM; MacIver JE; Geary CG; Delamore IW; Hull PJ; Tooth JA
    Br J Cancer; 1978 Feb; 37(2):282-8. PubMed ID: 272913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy of acute myelogenous leukemia in man.
    Powles R
    Natl Cancer Inst Monogr; 1973 Dec; 39():243-7. PubMed ID: 4595324
    [No Abstract]   [Full Text] [Related]  

  • 10. The early detection of remission in acute myelogenous leukaemia by in vitro cultures.
    Spitzer G; Dicke KA; McCredie KB; Barlogie B
    Br J Haematol; 1977 Mar; 35(3):411-8. PubMed ID: 265734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of immunotherapy on survival of patients with acute myelogenous leukaemia after relapse.
    Powles R; Toy JL
    Haematologia (Budap); 1976; 10(1):5-9. PubMed ID: 1070466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of active immunotherapy of acute myeloid leukemia.
    Mathé G; Musset M; Schwarzenberg L; Hayat M; de Vassal F; Amiel JL; Pouillart P; Misset JL
    Biomedicine; 1975 Sep; 23(7):291-3. PubMed ID: 1066168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial: Immunotherapy for acute myeloid leukaemia.
    Lancet; 1974 May; 1(7862):846-7. PubMed ID: 4132795
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunotherapy for acute myelogenous leukaemia.
    Powles RL; Crowther D; Bateman CJ; Beard ME; McElwain TJ; Russell J; Lister TA; Whitehouse JM; Wrigley PF; Pike M; Alexander P; Fairley GH
    Br J Cancer; 1973 Nov; 28(5):365-76. PubMed ID: 4271320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical applications of bone-marrow culture.
    Goldman JM; Sultan C
    Lancet; 1975 Oct; 2(7937):696-9. PubMed ID: 52063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of adult acute myelogenous leukaemia.
    Crowther D; Powles RL; Bateman CJ; Beard ME; Gauci CL; Wrigley PF; Malpas JS; Fairley GH; Scott RB
    Br Med J; 1973 Jan; 1(5846):131-7. PubMed ID: 4513355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oscillations of marrow culture growth in acute myeloid leukemia during remission induction and remission.
    Gustavsson A; Olofsson T; Olsson I
    Acta Haematol; 1979; 62(5-6):241-6. PubMed ID: 121664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active immunotherapy used alone for maintenance of patients with acute myeloid leukaemia.
    Freeman CB; Harris R; Geary CG; Leyland MJ; MaCiver JE; Delamore IW
    Br Med J; 1973 Dec; 4(5892):571-3. PubMed ID: 4519012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance chemoimmunotherapy of nonlymphoblastic acute leukemias.
    Favre R; Sebahoun G; Bagarry-Liégey D; Imbert C; Ciardelli P; Gastaut JA; Meyer G; Carcassonne Y
    Recent Results Cancer Res; 1982; 80():56-63. PubMed ID: 7036297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The place of immunological methods of treatment in the management of acute leukaemia.
    Powles RL; Russell JA
    Hamatol Bluttransfus; 1976; 19():297-304. PubMed ID: 795744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.